VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into CorMedix Inc. (CRMD) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $433M · P/E 2.7 · revenue $462M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows